Blue Trust’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Blue Trust's VKTX Position: Q3 2026 in Review
Blue Trust reduced its Viking Therapeutics (VKTX) stake by 18% in Q3 2026, selling an estimated $2.98K and leaving 396 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1633.
Blue Trust first reported a position in VKTX in Q3 2022 and has held it in 12 quarters since. The position peaked at $75.9K in Q4 2024. 359 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Blue Trust held 396 shares of Viking Therapeutics worth $12.9K as of Q3 2026.
- Blue Trust sold 86 Viking Therapeutics shares in Q3 2026, an estimated $2.98K.
- Viking Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1633 holding.
- Blue Trust first reported a position in Viking Therapeutics in Q3 2022 and has held it in 12 quarters since.
- Blue Trust's Viking Therapeutics position peaked at $75.9K in Q4 2024.
- 359 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.